Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Found 123 results
Author
Title
[
Type
]
Year
Filters:
Filter
is
[Clear All Filters]
Journal Article
DeFilippis EM
,
Longman R
,
Harbus M
,
Dannenberg K
,
Scherl EJ
. 2016.
Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.
.
Curr Gastroenterol Rep. 18(3):13.
Chen HJoyce
,
Sun J
,
Huang Z
,
Hou H
,
Arcilla M
,
Rakhilin N
,
Joe DJ
,
Choi J
,
Gadamsetty P
,
Milsom J
et al.
. 2015.
Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting.
.
Nat Biotechnol. 33(6):656-60.
Kumar A
,
Teslova T
,
Taub E
,
Miller JD
,
Lukin DJ
. 2020.
Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
.
Dig Dis Sci.
Steinlauf AF
,
Traube M
,
Neitlich JD
,
Cooney EL
. 1998.
Clostridium difficile colitis: a possible cause of unexplained elevation of serum alkaline phosphatase levels in patients with AIDS.
.
Clin Infect Dis. 26(5):1248-9.
Marion JF
,
Waye JD
,
Present DH
,
Israel Y
,
Bodian C
,
Harpaz N
,
Chapman M
,
Itzkowitz S
,
Steinlauf AF
,
Abreu MT
et al.
. 2008.
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
.
Am J Gastroenterol. 103(9):2342-9.
Huang C
,
Haritunians T
,
Okou DT
,
Cutler DJ
,
Zwick ME
,
Taylor KD
,
Datta LW
,
Maranville JC
,
Liu Z
,
Ellis S
et al.
. 2015.
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
.
Gastroenterology. 149(6):1575-86.
DeFilippis EM
,
Barfield E
,
Leifer D
,
Steinlauf A
,
Bosworth BP
,
Scherl EJ
,
Sockolow R
. 2015.
Cerebral venous thrombosis in inflammatory bowel disease.
.
J Dig Dis. 16(2):104-8.
Agrawal M
,
Arora S
,
Li J
,
Rahmani R
,
Sun L
,
Steinlauf AF
,
Mechanick JI
,
Zaidi M
. 2011.
Bone, inflammation, and inflammatory bowel disease.
.
Curr Osteoporos Rep. 9(4):251-7.
Battat R
,
Dulai PS
,
Casteele NVande
,
Evans E
,
Hester KD
,
Webster E
,
Jain A
,
Proudfoot JA
,
Mairalles A
,
Neill J
et al.
. 2019.
Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.
.
Inflamm Bowel Dis. 25(2):410-420.
Volger S
,
Scherl E
. 2021.
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy.
.
Clin Gastroenterol Hepatol.
Battat R
,
Ma C
,
Jairath V
,
Khanna R
,
Feagan BG
. 2019.
Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn's Disease and Ulcerative Colitis.
.
Drug Saf. 42(5):617-632.
Lukin DJ
,
Kumar A
,
Hajifathalian K
,
Sharaiha RZ
,
Scherl EJ
,
Longman RS
. 2020.
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
.
Gastroenterology. 159(4):1541-1544.e2.
Battat R
,
Hemperly A
,
Truong S
,
Whitmire N
,
Boland BS
,
Dulai PS
,
Holmer AK
,
Nguyen NH
,
Singh S
,
Casteele NVande
et al.
. 2021.
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
.
Clin Gastroenterol Hepatol. 19(3):511-518.e6.
Castellanos JG
,
Longman RS
. 2019.
The balance of power: innate lymphoid cells in tissue inflammation and repair.
.
J Clin Invest. 129(7):2640-2650.
Persley K
,
Scherl E
,
Rubin P
. 2001.
Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.
.
Am J Gastroenterol. 96(12):3444-5.
Yarur AJ
,
Deepak P
,
Casteele NVande
,
Battat R
,
Jain A
,
Okada L
,
Osterman M
,
Regueiro M
. 2021.
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
.
Dig Dis Sci. 66(10):3563-3569.
Battat R
,
Kopylov U
,
Bessissow T
,
Bitton A
,
Cohen A
,
Jain A
,
Martel M
,
Seidman E
,
Afif W
. 2017.
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease.
.
Clin Gastroenterol Hepatol. 15(9):1427-1434.e2.
Hassan-Zahraee M
,
Ye Z
,
Xi L
,
Baniecki MLynn
,
Li X
,
Hyde CL
,
Zhang J
,
Raha N
,
Karlsson F
,
Quan J
et al.
. 2021.
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
.
Inflamm Bowel Dis.
Verma HDev
,
Scherl EJanice
,
Jacob VElizabeth
,
Bosworth BPaul
. 2011.
Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab.
.
J Dig Dis. 12(5):379-83.
Battat R
,
Sandborn WJ
. 2021.
Advances in the Comprehensive Management of Postoperative Crohn's Disease.
.
Clin Gastroenterol Hepatol.
Viladomiu M
,
Metz ML
,
Lima SF
,
Jin W-B
,
Chou L
,
Guo C-J
,
Diehl GE
,
Simpson KW
,
Scherl EJ
,
Longman RS
. 2021.
Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.
.
Cell Host Microbe.
Borges LF
,
Jagadeesan V
,
Goldberg H
,
Gavini S
,
Lo W-K
,
Burakoff R
,
Feldman N
,
Chan WW
. 2018.
Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis.
.
J Neurogastroenterol Motil. 24(3):395-402.
Zhang S
,
Fu J
,
Dogan B
,
Scherl EJ
,
Simpson KW
. 2018.
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
.
J Antibiot (Tokyo). 71(11):950-961.
« first
‹ previous
1
2
3
4
5
(current)